Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Moving to better COPD care-changes to and challenges for GOLD.

American journal of respiratory and critical care medicine·2026

Same author

The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease.

Archivos de bronconeumologia·2026

Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026

Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026

Same author

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians.

Journal of clinical medicine·2026

Same author

Astegolimab for COPD With Frequent Exacerbations: Pooled Analysis of the ALIENTO and ARNASA Trials.

American journal of respiratory and critical care medicine·2026

Search research articles

Related Experiment Video

Updated: May 13, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Pathophysiology of muscle dysfunction in COPD.

Joaquim Gea¹, Alvar Agustí, Josep Roca

¹Servei de Pneumologia, Hospital del Mar-IMIM, Universitat Pompeu Fabra, Barcelona, Spain. jgea@parcdesalutmar.cat

Journal of Applied Physiology (Bethesda, Md. : 1985)

|March 23, 2013

Summary

This summary is machine-generated.

Chronic obstructive pulmonary disease (COPD) causes muscle dysfunction in respiratory and peripheral muscles. This review explores the complex factors contributing to COPD-related muscle weakness and its impact.

Keywords:

deconditioning exacerbations exercise hyperinflation limb muscles muscle dysfunction muscle wasting respiratory muscles

Related Experiment Videos

Last Updated: May 13, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

Area of Science:

Pulmonary Medicine
Exercise Physiology
Muscle Biology

Background:

Muscle dysfunction is prevalent in chronic obstructive pulmonary disease (COPD), affecting both respiratory and peripheral muscles.
This dysfunction leads to reduced exercise capacity, impaired daily activities, and ventilatory insufficiency.

Purpose of the Study:

To review the current understanding of the pathophysiology of muscle dysfunction in COPD patients.
To explore the interplay of local and systemic factors contributing to muscle impairment.

Main Methods:

Literature review of studies on COPD and muscle function.
Analysis of factors influencing respiratory and peripheral muscle pathophysiology.

Main Results:

Respiratory muscle dysfunction is linked to pulmonary hyperinflation and increased work of breathing.
Peripheral muscle dysfunction is primarily associated with deconditioning, alongside systemic factors like inflammation and nutritional deficits.
Both muscle types experience protein metabolism imbalance, oxidative stress, and injury, with distinct structural and functional changes observed.

Conclusions:

COPD-induced muscle dysfunction results from complex interactions between local and systemic factors.
Understanding these mechanisms is crucial for managing COPD patients and improving their quality of life.